Literature DB >> 4632660

Serum gold. I. Estimation by atomic absorption spectroscopy.

A A Dietz, H M Rubinstein.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4632660      PMCID： PMC1006061          DOI： 10.1136/ard.32.2.124

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  DETERMINATION OF GOLD IN SERUM AND URINE BY NEUTRON ACTIVATION ANALYSIS.

Authors:  S SOLVSTEN
Journal:  Scand J Clin Lab Invest       Date:  1964       Impact factor: 1.713

2.  SERUM VISCOSITY IN RHEUMATIC DISEASES AND MACROGLOBULINEMIA.

Authors:  M A SHEARN; W V EPSTEIN; E P ENGLEMAN
Journal:  Arch Intern Med       Date:  1963-11

3.  METABOLISM, TOXICITY AND MANNER OF ACTION OF GOLD COMPOUNDS USED IN THE TREATMENT OF ARTHRITIS. I. HUMAN PLASMA AND SYNOVIAL FLUID CONCENTRATION AND URINARY EXCRETION OF GOLD DURING AND FOLLOWING TREATMENT WITH GOLD SODIUM THIOMALATE, GOLD SODIUM THIOSULFATE, AND COLLOIDAL GOLD SULFIDE.

Authors:  R H Freyberg; W D Block; S Levey
Journal:  J Clin Invest       Date:  1941-07       Impact factor: 14.808

4.  Gold determination in biological fluids by atomic absorption spectrophotometry: application to chrysotherapy in rheumatoid arthritis patients.

Authors:  A Lorber; R L Cohen; C C Chang; H E Anderson
Journal:  Arthritis Rheum       Date:  1968-04

5.  Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis.

Authors:  F E Krusius; A Markkanen; P Peltola
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

6.  A comparison between the amounts of As, Au, Br, Cu, Fe, Mo, Se and Zn in normal and uraemic human whole blood by means of neutron activation analysis.

Authors:  D Brune; K Samsahl; P O Wester
Journal:  Clin Chim Acta       Date:  1966-03       Impact factor: 3.786
  6 in total
  1 in total

1.  Serum gold. II. Levels in rheumatoid arthritis.

Authors:  H M Rubinstein; A A Dietz
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.